Viewing Study NCT02054793


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-02-21 @ 11:17 PM
Study NCT ID: NCT02054793
Status: WITHDRAWN
Last Update Posted: 2014-07-23
First Post: 2014-01-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)
Sponsor: Emmanuel Antonarakis, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
None Castration-resistant Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic disease View
None non-metastatic disease View
None prostate cancer View
None castration-resistant prostate cancer View